☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
ReAlta Life Sciences
ReAlta Life Sciences’ RLS-0071 Gains the US FDA’s ODD & FTD to Treat Steroid-Refractory aGvHD
August 23, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.